EUVIMEDEUVIMED entdecken
Crossref

GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy

Takashi Kokumai, Yuko Omori, Masaharu Ishida, Hideo Ohtsuka, Masamichi Mizuma, Kei Nakagawa, Chiho Maeda, Yusuke Ono, Yusuke Mizukami, Shin Miura, Kiyoshi Kume, Atsushi Masamune und 3 weitere

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Takashi Kokumai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Surgery, Tohoku University Graduat…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Pancreatic Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relevant protein expression of GATA6, CK5, vimentin, and mucins using immunohistochemistry was assessed for predicting the prognosis of and chemotherapy efficacy in patients with pancreatic cancers (PCs). The protein expression was examined in 159 PCs resected after neoadjuvant chemotherapy (NAC-PCs) and compared with that of 120 matched biopsy specimens taken before NAC. KRAS mutations were assessed by digital PCR. NAC-PCs were classified by GATA6 expression initially and CK5 expression subsequently into 4 types: classical-type (n = 22) with GATA6-high (≥50%)/CK5-low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorPancreatic NeoplasmsHumansVimentinNeoadjuvant TherapyProto-Oncogene Proteins p21(ras)PrognosisGATA6 Transcription Factor

Stichwörter der Autor:innen

CK5GATA6immunohistochemical phenotypingneoadjuvant chemotherapypancreatic cancer

Substanzen

VimentinBiomarkers, TumorProto-Oncogene Proteins p21(ras)GATA6 protein, humanGATA6 Transcription Factor

Autor:innen und Institutionen

  • Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan; Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
  • Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
  • Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan; Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Zitieren

APA

Kokumai, T., Omori, Y., Ishida, M., Ohtsuka, H., Mizuma, M., Nakagawa, K., Maeda, C., Ono, Y., Mizukami, Y., Miura, S., Kume, K., Masamune, A., Morikawa, T., Unno, M., & Furukawa, T. (2023). GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100102

Vancouver

Kokumai T, Omori Y, Ishida M, Ohtsuka H, Mizuma M, Nakagawa K, et al. GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100102

BibTeX
@article{Kokumai2023,
  author = {Kokumai, Takashi and Omori, Yuko and Ishida, Masaharu and Ohtsuka, Hideo and Mizuma, Masamichi and Nakagawa, Kei and Maeda, Chiho and Ono, Yusuke and Mizukami, Yusuke and Miura, Shin and Kume, Kiyoshi and Masamune, Atsushi and Morikawa, Takanori and Unno, Michiaki and Furukawa, Toru},
  title = {GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100102}
}
Kostenlos starten →